Market Highlights Increasing prevalence of Merkel cell carcinoma and growing geriatric population are estimated to be the major drivers for the market growth during the forecast period. Moreover, increasing R&D expenses by the key market players, rising mortality rate by MCC, and growing healthcare expenditure is further boosting the market growth. However, the high cost of therapeutics and related side effects along with the lack of awareness and low per capita healthcare expenditures in the developing economies restrains the market growth. Segmentation on the basis of diagnosis, treatment, and end users.
Get a free sample @ https://www.marketresearchfuture.com/sample_request/5343 Intended Audience Pharmaceutical Companies Biotechnological Institutes Government and Private Laboratories Research and Development (R&D) Companies Medical Research Laboratories Market Research and Consulting Service Providers Regional Analysis The Americas dominate the global Merkel cell carcinoma market. Presence of a well-developed healthcare sector and high per capita healthcare expenditures provides favorable backgrounds for market growth within the region. Additionally, the presence of the major market players within the region fuels the market growth. Followed by the Americas, Europe leads the Merkel cell carcinoma market. Availability of funds for research, huge patient population, and government support for research & development is estimated to drive the market growth within the region. Asia Pacific is the fastest growing region for the market due to the presence of economies like India, Australia, and China and developing healthcare sector in the market. Increasing prevalence of skin cancer, growing geriatric population, and rising healthcare expenditure boost the market growth within the region. On the other hand, the Middle East & Africa has the least share in the Merkel cell carcinoma market due to the presence of poor economies and stringent government policies, especially in the African region. Majority of the market of this region is held by the Middle East. Key Players Pfizer Inc. (U.S.) Merck & Co., Inc. (U.S.) OncoSec Medical Incorporated (U.S.) Bristol-Myers Squibb Company (U.S.) General Electric Company (U.S.) Siemens Medical Solutions USA, Inc. (Germany) CANON MEDICAL SYSTEMS CORPORATION (Japan) Philips Health Care (The Netherlands) AstraZeneca (U.K) Mediso Ltd. Endomagnetics Limited (Hungary) Browse Full Report @ https://www.marketresearchfuture.com/reports/merkel-cell-carcinoma-market-5343 . About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. Contact: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India +1 646 845 9312 Email: [email protected] .
0 Comments
Global Legg-Calve-Perthes Disease Treatment Market: Type (Surgical and Non-Surgical Methods), Application (Osteoarthritis, Hip Dislocation, Hip Fracture), Age Group (4-6, 6-11 and 12-19 years), End-User (Hospitals and Clinics)–Global Forecast Till 2023 Legg-Calve-Perthes is a disease which occurs when the blood supply to the femoral head (upper end of the thigh bone) which fits in the hip socket temporarily stops to flow. As an outcome, the femoral head is no longer round and does not move smoothly in the hip socket, resulting in hip pain and constrained leg movements. Individuals suffering from the disease go on developing a painful joint disorder called as hip osteoarthritis at an early age. Rising frequencies of hip osteoarthritis due to the increasing number of elderly population and increase in health care expenditure are expected to boost the Legg-Calve-Perthes Disease Treatment Market growth during the forecast period. The side effects of the treatment and strict monitoring policies for management of drugs will hamper the market growth. The global legg-calve-Perthes disease treatment market is expected to register a significant growth during the forecast period (2018–2023). Key Players of the market · BASF, · Albemarle, · Sunline, · IOLCP, · Shandong Xinhua Pharmaceutical Co. Ltd, · Dr. Reddy's, · DePuy Synthes, · Prime Medical, · Zimmer, · Biomet Holdings, Inc., · 3M Healthcare, · Össur Hf, · DJO, · Stryker Corporation. Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/6345 Segmentation The global legg-calve-perthes disease treatment market has been segmented on the basis of type, application, age group, and end-users. On the basis of type, the market has been classified as non-surgical and surgical methods. The non-surgical method is segmented in to anti-inflammatory medications, casting and bracing, crutches, and others. Casting and bracing is further segmented into newington brace, toronto orthosis, scottish rite orthosis, broomstick plasters, and birmingham orthosis. The others segment is further sub-segmented in to conventional calipers, snyder slings, slings with crutches, and traction. The surgical method is segmented in to femoral osteotomy, innominate osteotomy, combination of femoral osteotomy, and innominate osteotomy. On the basis of application, the market has been classified as hip fracture, hip dislocation, osteoarthritis, and congenital dysplasia of the hip. Intended Audience · Advanced Surgical Trainees · Governmental Agency · Educational Organizations · Medical Device Manufacturers · Research Institutes and Academic Centers · Market Research and Consulting Access the full report @ https://www.marketresearchfuture.com/reports/legg-calve-perthes-disease-market-6345 Regional Analysis The North American region holds the largest share of the market. The change in lifestyle and availability of advanced medical technologies help the market to grow. Healthcare insurance policies are the most important factor that contributes for the growth of the market in this region. The European market is determined by fluctuating government policies to support drug manufacturers to develop advanced treatment options. The changing policies are likely to fuel the revenue growth of the market. The European market accounts to hold the second largest share of the market due to rising patient population. Asia-Pacific is expected to be the fastest growing region. Factors such as huge patient base population and presence of developing economies and medical tourism help to boost the market. Beneficial government strategies and rise in healthcare expenditure also fuel the market growth. About Us: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Media Contact: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India +1 646 845 9312 Email: [email protected] Bioburden Testing Market 2019 | Segmentation, Regional Analysis, Global Players and Forecast 20239/19/2019 Bioburden Testing Market - Highlights Bioburden testing refers to an estimation of microbial load on a medical instrument, raw material, packaged goods among others. Several factors such as rising medical spending, increasing food safety concerns and growing product recalls due to microbial contamination are projected to drive the growth of the market. On the other hand, high costs of microbial enumeration instruments and complex and time-consuming regulatory standards in some economies may curb the market growth during the assessment period. The Global Bioburden Testing Market is expected to register a CAGR of Approx. 9.15% during the forecast period of 2018–2023 with an estimated market value of USD 455 million. Moreover, test reports and certificates tend to be different from one country to another which hampers international trade. Therefore, in December 2017, International Organization for Standardization (ISO) published a new edition of ISO/IEC 17025 standard. This standard is an international reference for laboratories carrying out calibration and testing activities around the world. ISO/IEC 17025 helps facilitate cooperation between laboratories and other bodies by creating widespread acceptance of results between countries. The global bioburden testing market is currently dominated by many market players. The key players in the market are involved in new product launches and strategic collaborations to strengthen its market position. For instance, in October 2018, Becton, Dickinson and Company, a leading global medical technology company, announced the availability of the BD MAX MDR-TB (multi-drug resistant tuberculosis) panel in Europe. Get a free sample @ https://www.marketresearchfuture.com/sample_request/6716 Regional Analysis: The market in the Americas is expected to dominate the global bioburden testing market during the forecast period owing to the presence of well-established healthcare system, increasing healthcare expenditure, and favorable reimbursement scenario. The European market is expected to be the second-largest due to availability of funds for research from public and private sources. Moreover, the market in Asia-Pacific is predicted to be the fastest-growing during the assessment period owing to growing disposable income, and continuously developing economies. The market in the Middle East & Africa is likely to account for the smallest share of the global bioburden testing market. The market growth in this region can be attributed to the growing government initiatives. Segmentation: The global bioburden testing market has been segmented into test type, product type, application and end-user. The market, on the basis of type, has been segmented into aerobic count, anaerobic count, fungi count and spore count. The market, on the basis of product type, has been segmented into consumables and instruments. The market, by consumables, has been sub-segmented into reagents and kits, and others. The market, by instruments, has been further segmented into polymerase chain reaction machine (PCR), microscopes, and others. The market, by application, has been segmented into raw materials testing, medical devices testing, in-process material testing, sterilization validation testing, and equipment cleaning validation. The market, by end-user, has been segmented into pharmaceutical and biotechnology companies, microbial testing laboratories, and others. Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/bioburden-testing-market-6716 Key Players: Some of the key players in the global bioburden testing market are WuXi AppTec, Charles River, SGS SA, Merck KGaA, NORTH AMERICAN SCIENCE ASSOCIATES INC., Becton, Dickinson, and Company, Nelson Laboratories, LLC, Pacific Biolabs, ATS Laboratories, Inc., and Dynatec Labs. Contact: Market Research Future +1 646 845 9312 Email: [email protected] . Market Highlights Sterilization equipment are necessary to maintain the sterile conditions during research activities, manufacturing of pharmaceuticals and during medical procedures. The increasing geriatric population, a growing number of surgical procedures and increasing research and development activities in the healthcare sector are the major factors driving the growth of the global sterilization equipment market. Additionally, increasing R&D spending and aggressive strategies adopted by the top players, such as new product launches, are contributing to the growth of the market. For instance, in August 2018, Cantel Medical announced the acquisition of Stericycle's Controlled Environmental Solutions Business for USD 17 million, it is a leading provider of testing and certification, environmental monitoring and decontamination services for clean rooms, and other services related to regulatory compliance and quality control The high costs associated with surgeries, stringent regulatory environment for product approval, and lack of awareness about sterilization methods are likely to hinder the market growth during the forecast period. Get a free sample @ https://www.marketresearchfuture.com/sample_request/6397 Regional Analysis The market in the Americas is expected to dominate the global sterilization equipment market during the forecast period owing to the increasingly strict sterility guidelines, increase in the number of surgical procedures due to rising geriatric population, the presence of a well-established healthcare system and adoption of highly advanced technology. The European market is expected to be the second-largest due to the increasing government expenditure on healthcare and increasing research activities in the life sciences sector, and the growing number of road accidents in Europe. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to the increasing geriatric population in the region, increasing number of hospitals in Asia, and favorable government initiatives for healthcare facilities. The market in the Middle East & Africa is likely to account for the smallest share of the global sterilization equipment market. Segmentation The global sterilization equipment market has been segmented on the basis of product, technology, and end-user. On the basis of product, the market has been classified as heat sterilization, low-temperature sterilization, filtration sterilization, ionizing radiation sterilization. The heat sterilization segment has been further divided into dry heat sterilization and moist heat sterilization. The Low-temperature sterilization segment has been further divided into ethylene oxide sterilization, hydrogen peroxide sterilization, and others. The ionizing radiation sterilization segment has been classified as electron beams and gamma rays. The technology segment has been divided into steam, forced convention, vacuum, gravity, and natural convection. The market, by end–user, has been segmented into hospitals & clinics, research institutes, pharmaceutical companies, food & beverage industry, medical device companies, and other end–users. Access Report @ https://www.marketresearchfuture.com/reports/sterilization-equipment-market-6397 Key Players Some of the key players in the global sterilization equipment market are 3M, STERIS plc., Getinge AB, Sotera Health, Advanced Sterilization Products (Division of Ethicon), Belimed, Anderson Products, Boekel Scientific, Celitron Medical, Technologies Kft., Fedegari Autoclavi S.p.A., Cantel Medical., LTE Scientific, Merck & Co., Inc, Midmark Corporation, MMM Group, TSO3 INC., and SAKURA SI CO., LTD. About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. Market Highlights
The Global Animal Vaccines Market is expected to grow at an approximate CAGR of 5.65% during forecast period, 2018–2023. Increasing participation of market players is the key factor driving the animal vaccines market. For instance, in 2015, Boehringer Ingelheim launched two new swine vaccines against Porcine Reproductive and Respiratory Syndrome (PRRS) i.e. Ingelvac PRRSFLEX EU for piglets and ReproCyc PRRS EU for breeding gilts. Various other factors such as increasing incidence of livestock diseases, technological advancements, increasing adoption of companion animals, and rising government initiatives are also expected to propel the growth of the market. However, high storage costs for vaccines, and inadequate surveillance and reporting systems can hinder the market growth over the forecast period. Request a free sample @ https://www.marketresearchfuture.com/sample_request/7184 Segmentation The Global Animal Vaccines Market is segmented based on type, technology, indications, composition and region. The Global Animal Vaccines Market, by type is segmented into static porcine vaccines, poultry vaccines, livestock vaccines, companion animal vaccines, aquaculture vaccines, and others. The livestock vaccine is further segmented into bovine vaccines, and small ruminant vaccines. The livestock vaccine is further segmented into canine vaccines, and feline vaccines. The market, by technology, is segmented into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, and others. Based on indications, the market is segmented into foot & mouth disease, parvovirus, distemper, reproductive & respiratory syndrome, and others. Based on composition, the market is segmented into mono vaccine, and combination vaccines. Access the full report @ https://www.marketresearchfuture.com/reports/animal-vaccines-market-7184 Regional Analysis The Americas dominated the global market for animal vaccines owing to the presence of major market players, rising pet adoption and developed economies like US and Canada within the region. According to the American Society for the Prevention of Cruelty to Animals (ASPCA), nearly 6.5 million companion animals enter US animal shelters nationwide every year. In 2017, it was estimated that Europe stood second in the global animal vaccines market. This can be attributed to the rising research and development investments. For instance, in 2018, Boehringer Ingelheim announced to reinforce its leading position in the veterinary vaccine market with 70 million euro investment in the R&D and biological production activities. Asia Pacific was projected to be the fastest growing region in 2017. Increasing awareness about animal health drives the regional markets of the Asia Pacific region. In 2016, at the 5th Global Animal Health Conference, HealthforAnimals association called for greater cooperation between national governments to improve market access for veterinary medicines. On the other hand, the Middle East and Africa held least share in the global animal vaccines market due to the low per capita income, especially within the African region. The market growth in this region is expected to be driven by increasing cases of zoonotic diseases. According to a 2015 study published in the PLOS journal, annual incidences of human rabies in the Middle Eastern countries vary from 0.02 to 1.3 per million human populations. Key Players Some of the key players in the global animal vaccines market are Bayer AG, Biogenesis Bago, Boehringer Ingelheim GmbH, China Animal Husbandry, Elanco Animal Health, Hester, Idt Biologika, Indian Immunologicals Limited, Merck Animal Health, MSD Animal Health, Phibro Animal Health, Tianjin Ringpu, Vetoquinol, Zoetis Inc., and others. About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. Contact: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India +1 646 845 9312 Email: [email protected] |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
June 2021
Categories |